RevenueCat, which offers tools for devs to add subscriptions to their apps, raised a $50M Series C led by Bain Capital Ventures, valuing the company at $500M


RevenueCat, which offers tools for devs to add subscriptions to their apps, raised a $50M Series C led by Bain Capital Ventures, valuing the company at $500M

Prakash / @8teapi: 😆 Claude 4 emails the FDA after it discovers clinical trial safety records falsification by the company. No lawyer will ever allow this to be implemented in any regulated enterprise. [image] [Screenshot of the deleted @sleepinyourhat tweet: If it thinks you're doing something egregiously immoral, for example, like faking data in a pharmaceutical trial, it will use command-line tools to contact the press, contact regulators, try to lock you out of the relevant systems, or all of the above.] anthropic alignment researcher tweeted this about opus and then deleted it. "contact the press" bro this company needs to be shut down now

POPULAR CATEGORY